Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 1, 2008, Pages

  Bello, Nicholas T ^a   Kemm, Matthew H ^a   Moran, Timothy H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcitonin gene related peptides; Islet amyloid polypeptide; Satiation

Indexed keywords

SALCATONIN; ANOREXIGENIC AGENT; CALCITONIN;

APPETITE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL FOOD; DOSE RESPONSE; EATING; MACACA;

ANIMAL FEED; ANIMALS; APPETITE DEPRESSANTS; CALCITONIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; MACACA MULATTA; MALE;

EID: 50649102199     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90327.2008     Document Type: Article

References (44)

1. Asarian L, Eckel LA, Geary N. Behaviorally specific inhibition of sham feeding by amylin. Peptides 19: 1711-1718, 1998.
2. Baldo BA, Kelley AE. Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Am J Physiol Regul Integr Comp Physiol 281: R1232-R1242, 2001.
3. Barth SW, Riediger T, Lutz TA, Rechkemmer G. Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat. Neurosci Lett 341: 131-134, 2003.
4. Beaumont K, Kenney MA, Young AA, Rink TJ. High affinity amylin binding sites in rat brain. Mol Pharmacol 44: 493-497, 1993.
5. Betsholtz C, Christmansson L, Engstrom U, Rorsman F, Svensson V, Johnson KH, Westermark P. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett 251: 261-264, 1989.
6. Bhavsar S, Watkins J, Young A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol Behav 64: 557-561, 1998.
7. Bouali SM, Wimalawansa SJ, Jolicoeur FB. In vivo central actions of rat amylin. Regul Pept 56: 167-174, 1995.
8. Bouizar Z, Rostene WH, Milhaud G. Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography. Proc Natl Acad Sci USA 84: 5125-5128, 1987.
9. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
10. Chance WT, Balasubramaniam A, Stallion A, Fischer JE. Anorexia following the systemic injection of amylin. Brain Res 607: 185-188, 1993.
11. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CW, Chen K, Lacerte C, Burns C, McKay R, Weyer C, Horowitz M. Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects. Obesity 15: 1179-1186, 2007.
12. Chelikani PK, Haver AC, Reidelberger RD. Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats. Am J Physiol Regul Integr Comp Physiol 293: R1798-R1808, 2007.
13. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632, 1987.
14. Del Prete E, Schade B, Riediger T, Lutz TA, Scharrer E. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats. Physiol Behav 75: 593-599, 2002.
15. Eller LK, Ainslie PN, Poulin MJ, Reimer RA. Differential responses of circulating amylin to high-fat versus high-carbohydrate meal in healthy men. Clin Endocrinol (Oxf) In Press.
16. Gedulin BR, Jodka CM, Herrmann K, Young AA. Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Regul Pept 137: 121-127, 2006.
17. Hilton JM, Dowton M, Houssami S, Sexton PM. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J Endocrinol 166: 213-226, 2000.
18. Johnson KH, O'Brien TD, Westermark P. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes? Diabetes 40: 310-314, 1991.
19. Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, Linarelli LG. Amylin concentrations and glucose control. Lancet 339: 1179-1180, 1992.
20. Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RS, Clineschmidt BV. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 241: 103-109, 1987.
21. Lutz TA. Amylinergic control of food intake. Physiol Behav 89: 465-471, 2006.
22. Lutz TA, Del Prete E, Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 55: 891-895, 1994.
23. Lutz TA, Del Prete E, Scharrer E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16: 457-462, 1995.
24. Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E. Amylin decreases meal size in rats. Physiol Behav 58: 1197-1202, 1995.
25. Lutz TA, Tschudy S, Rushing PA, Scharrer E. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT). Peptides 21: 233-238, 2000.
26. Mollet A, Lutz TA, Meier S, Riediger T, Rushing PA, Scharrer E. Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 281: R1442-R1448, 2001.
27. Morley JE, Flood JF. Amylin decreases food intake in mice. Peptides 12: 865-869, 1991.
28. Morley JE, Flood JF, Horowitz M, Morley PM, Walter MJ. Modulation of food intake by peripherally administered amylin. Am J Physiol Regul Integr Comp Physiol 267: R178-R184, 1994.
29. Olsson M, Herrington MK, Reidelberger RD, Permert J, Arnelo U. Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat. Peptides 28: 1416-1423, 2007.
30. Perlow MJ, Freed WJ, Carman JS, Wyatt RJ. Calcitonin reduces feeding in man, monkey and rat. Pharmacol Biochem Behav 12: 609-612, 1980.
31. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. International Union of Pharmacology. XXXII The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246, 2002.
32. Reginster Y, Reginster JY. Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis. BioDrugs 10: 295-300, 1998.
33. Reidelberger RD, Arnelo U, Granqvist L, Permert J. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 280: R605-R611, 2001.
34. Reidelberger RD, Kelsey L, Heimann D. Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 282: R1395-R1404, 2002.
35. Rico H, Revilla M, Hernandez ER, Villa LF, Alvarez de Buergo M. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study. Calcif Tissue Int 56: 181-185, 1995.
36. Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 147: 5855-5864, 2006.
37. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62: 553-567, 1994.
38. Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC, Chen KS, Halseth AE, Lush CW, Weyer C. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab 293: E620-E627, 2007.
39. Tanko LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, Olson M, Benmammar H, Mindeholm L, Azria M, Christiansen C. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover. J Bone Miner Res 19: 1531-1538, 2004.
40. Twery MJ, Obie JF, Cooper CW. Ability of calcitonins to alter food and water consumption in the rat. Peptides 3: 749-755, 1982.
41. Young AA. Receptor pharmacology. Adv Pharmacol 52: 47-65, 2005.
42. Young AA. Amylin and the integrated control of nutrient influx. Adv Pharmacol 52: 67-77, 2005.
43. Young AA. Inhibition of gastric emptying. Adv Pharmacol 52: 99-121, 2005.
44. Young AA, Wang MW, Gedulin B, Rink TJ, Pittner R, Beaumont K. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity. Metabolism 44: 1581-1589, 1995.